시장보고서
상품코드
1927706

의약품 레퍼런스 앱 시장 : 가격 모델별, 디바이스별, 용도별, 최종 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 점유율 및 예측(2025-2032년)

Drug Reference Apps Market, By Pricing Model, By Device, By Application, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, and Market Share & Forecast from 2025-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 312 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

의약품 레퍼런스 앱 시장 규모는 2024년에 12억 5,930만 달러로 평가되었고, 2025-2032년 CAGR 9.11%로 성장할 것으로 예측됩니다.

의료진과 환자들이 디지털 헬스 툴을 적극적으로 활용하는 가운데, 세계 의약품 레퍼런스 앱 시장은 견조한 성장세를 보이고 있습니다. 이 용도는 복용량 권장량, 잠재적 약물 상호작용, 금기 사항, 최신 임상 정보 등 광범위한 의약품 정보에 즉각적으로 접근할 수 있도록 지원합니다. 이러한 도구는 의사결정 과정을 효율화함으로써 의료 서비스 제공의 효율성과 정확성을 높입니다. 또한, 원격 의료 및 원격 환자 관리의 확산으로 인해 사용자가 약물에 대한 정보에 입각한 선택을 할 수 있는 신뢰할 수 있는 디지털 리소스에 대한 수요가 증가하고 있습니다. 그 결과, 의약품 레퍼런스 앱은 현대 의학에서 환자 치료 및 치료 결과 개선에 필수적인 요소로 자리 잡고 있습니다.

의약품 레퍼런스 앱 시장 역학

의료 분야 디지털 의사결정 지원 도구 보급 확대

디지털 의사결정 지원 솔루션에 대한 의존도가 높아지는 것은 의약품 레퍼런스 앱 시장의 중요한 촉진요인입니다. 임상적 판단이 복잡해짐에 따라 의료진은 약물 관련 정보에 대한 빠르고 정확하며 신뢰할 수 있는 접근을 점점 더 많이 요구하고 있습니다. 이 앱은 적응증, 투약 가이드라인, 부작용, 잠재적 약물 상호작용 등 필수 데이터에 대한 즉각적인 액세스를 제공하여 정보에 입각한 의사결정을 돕고, 처방의 정확성과 환자 안전성을 향상시키는 데 기여합니다. 또한, 임상 가이드라인의 실시간 업데이트 및 통합을 통해 약물 부작용의 주요 원인 중 하나인 약물 오남용의 위험을 크게 줄일 수 있습니다. 예를 들어, 2025년 9월 True Rx Health Strategists는 True Rx+ 모바일 앱을 출시하여 환자와 이해관계자가 약국 혜택 관리, 약가 비교, 실시간 지원 서비스를 이용할 수 있도록 했습니다. 이는 약물 관련 의사결정을 지원하고 의료 워크플로우를 효율화하기 위한 디지털 도구의 채택이 확대되고 있음을 보여줍니다.

의약품 레퍼런스 앱 시장 : 세분화 분석

세계 의약품 레퍼런스 앱 시장은 가격 모델, 기기, 용도, 최종 용도, 지역을 기준으로 세분화되어 있습니다.

제공 내용에 따른 분류는 소프트웨어 플랫폼과 서비스로 구분됩니다. 소프트웨어 플랫폼은 데이터 분석과 AI 기반 엔진으로 개인화된 식단 추천을 가능하게 하는 소프트웨어 플랫폼이 큰 비중을 차지하고 있으며, 서비스는 컨설팅, 도입 지원, 지속적인 사용자 참여를 지원합니다.

가격 모델에 따른 분류는 무료, 구독형, 프리미엄형으로 구분됩니다. 구독형은 지속적인 업데이트와 기능 제공으로 특히 인기가 높으며, 무료 모델은 보다 폭넓은 사용자 기반을 확보할 수 있고, 프리미엄 모델은 기본 기능을 제공하면서 업그레이드 선택권을 제공합니다.

디바이스별로는 스마트폰, 태블릿, 데스크톱으로 분류됩니다. 휴대성과 편의성 때문에 스마트폰이 주류를 이루고 있지만, 태블릿은 더 큰 화면의 조작 경험을 제공하고, 데스크톱은 전문적인 환경에서 세부적인 활용을 위해 선호됩니다.

용도별로는 의약품 정보 및 상호작용 확인, 임상 의사결정 지원, 환자 교육, 기타로 분류됩니다. 의약품 정보 시스템은 안전성과 유효성 확보에 필수적이며, 임상 의사결정 지원은 의료진의 정보에 입각한 판단을 돕고, 환자 교육은 치료 옵션에 대한 이해 증진에 기여합니다.

최종 용도별로는 의료 종사자, 병원 및 클리닉, 약국, 환자 등으로 분류됩니다. 의료진은 환자 진료 개선에, 병원 및 클리닉은 업무 효율화에, 약국은 안전 확인에, 환자는 자가 관리 및 정보 수집에 각각 이러한 도구를 활용하고 있습니다.

의약품 레퍼런스 앱 시장 - 지역별 분석

의약품 레퍼런스 앱 시장은 높은 의료비 지출, 첨단 기술 도입, 강력한 규제 프레임워크로 인해 북미가 가장 큰 시장 점유율을 차지하고 있습니다. 주요 제약사의 존재와 디지털 헬스 솔루션에 대한 강력한 집중은 이러한 우위를 더욱 강화하고 있습니다. 북미에 이어 유럽은 의료 혁신에 대한 정부의 강력한 지원과 효율적인 의료 솔루션에 대한 수요 증가에 힘입어 중요한 위치를 차지하고 있습니다. 아시아태평양에서는 중산층 증가, 스마트폰 보급 확대, 디지털 헬스 활용에 대한 인식 개선 등을 배경으로 빠른 성장세를 보이고 있습니다. 한편, 중동 및 아프리카은 의료 인프라 개선과 기술 투자 증가의 영향을 받아 잠재적인 시장으로 점차 부상하고 있습니다. 전반적으로 지역별로 보면 북미가 선두를 달리고 유럽이 그 뒤를 따르고 있으며, 아시아태평양, 중동 및 아프리카는 유망한 성장세를 보일 것으로 예측됩니다.

의약품 레퍼런스 앱 시장 - 국가별 분석

의약품 레퍼런스 앱 시장은 미국이 주도하고 있으며, 선진 의료 시스템, 높은 기술 도입률, 디지털 헬스 혁신에 대한 막대한 투자로 지배적인 위치를 차지하고 있습니다. 신뢰할 수 있는 의약품 정보 및 임상 의사결정 지원에 대한 수요가 이러한 용도의 성장을 주도하고 있습니다. 미국 다음으로 유럽에서는 독일이 두드러진 존재감을 보이고 있으며, 엄격한 의료 규제와 환자 안전에 대한 강조는 의약품 참조 도구의 견고한 시장 형성을 촉진하고 있습니다. 영국도 국가보건서비스(NHS) 내에서 디지털 헬스 솔루션에 대한 중요성이 높아지면서 크게 기여하고 있습니다. 아시아에서는 중국과 인도가 빠르게 성장하고 있으며, 급증하는 스마트폰 사용, 의료에 대한 인식 증가, 접근 가능한 건강 정보를 원하는 인구 증가가 이를 주도하고 있습니다. 이들 국가의 의료 환경의 변화로 인해 의약품 레퍼런스 앱의 잠재력이 부각되고 있으며, 의약품 레퍼런스 앱 분야에서 중요한 시장으로 부상하고 있습니다.

목차

제1장 의약품 레퍼런스 앱 시장 개요

제2장 주요 요약

제3장 의약품 레퍼런스 앱 주요 시장 동향

제4장 의약품 레퍼런스 앱 시장 : 산업 분석

제5장 의약품 레퍼런스 앱 시장 : 높아지는 지정학적 긴장의 영향

제6장 의약품 레퍼런스 앱 시장 구도

제7장 의약품 레퍼런스 앱 시장 : 가격 모델별

제8장 의약품 레퍼런스 앱 시장 : 디바이스별

제9장 의약품 레퍼런스 앱 시장 : 용도별

제10장 의약품 레퍼런스 앱 시장 : 최종 용도별

제11장 의약품 레퍼런스 앱 시장 : 지역별

제12장 주요 벤더 분석 : 의약품 레퍼런스 앱 업계

제13장 AnalystView의 전방위적 분석

LSH

The Drug Reference Apps Market size was valued at US$1,259.30 Million in 2024, expanding at a CAGR of 9.11% from 2025 to 2032.

The global drug reference apps market is experiencing robust growth as healthcare professionals and patients increasingly embrace digital health tools. These applications offer immediate access to extensive drug information, including dosage recommendations, potential drug interactions, contraindications, and the latest clinical updates. By streamlining the decision-making process, these tools enhance the efficiency and accuracy of healthcare delivery. Furthermore, the rise in telemedicine and remote patient management has fueled demand for reliable digital resources that empower users to make informed choices about medications. As a result, drug reference apps are becoming essential for improving patient care and outcomes in modern healthcare.

Drug Reference Apps Market- Market Dynamics

Growing adoption of digital decision-support tools in healthcare

The increasing reliance on digital decision-support solutions is a significant driver of the Drug Reference Apps market. As the complexity of clinical decisions rises, healthcare professionals are increasingly seeking quick, accurate, and reliable access to drug-related information. These apps facilitate informed decision-making by providing instant access to essential data, including drug indications, dosing guidelines, side effects, and potential drug interactions, thereby improving prescribing accuracy and patient safety. Additionally, the risk of medication errors one of the leading causes of adverse drug events can be significantly reduced through real-time updates and integration of clinical guidelines. For instance, in September 2025, True Rx Health Strategists launched the True Rx+ mobile app, enabling patients and healthcare stakeholders to manage pharmacy benefits, compare medication prices, and access live support, highlighting the growing adoption of digital tools to support medication-related decision-making and streamline healthcare workflows

.Drug Reference Apps Market- Segmentation Analysis:

The Global Drug Reference Apps Market is segmented on the basis of Pricing Model, Device, Application, End Use, and Region.

Based on Offering, the market is categorized into Software Platforms and Services. Software platforms hold a significant share as they enable personalized dietary recommendations through data analytics and AI-driven engines, while services support consultation, implementation, and ongoing user engagement.

Based on Pricing Model, the market is categorized into Free, Subscription-Based, and Freemium. The subscription-based model is particularly popular as it provides users with consistent updates and features, while free models attract a larger user base, and freemium models offer basic functionalities with the option to upgrade.

Based on Device, the market is categorized into Smartphones, Tablets, and Desktops. Smartphones dominate due to their portability and convenience, while tablets offer a larger screen experience, and desktops are preferred for more in-depth usage in professional settings.

Based on Application, the market is categorized into Drug Information & Interaction Checking, Clinical Decision Support, Patient Education, and Others. Drug information systems are essential for safety and efficacy, while clinical decision support aids healthcare providers in making informed choices, and patient education enhances understanding of treatment options.

Based on End Use, the market is categorized into Healthcare Professionals, Hospitals & Clinics, Pharmacies, and Patients. Healthcare professionals leverage these tools for better patient care, hospitals and clinics integrate them into their systems for streamlined operations, pharmacies utilize them for safety checks, and patients use applications for self-management and information.

Drug Reference Apps Market- Geographical Insights

The Drug Reference Apps market is predominantly led by North America, which captures the largest market share due to high healthcare expenditures, advanced technology adoption, and a robust regulatory framework. The presence of major pharmaceutical companies and a strong emphasis on digital health solutions further bolster this dominance. Following North America, Europe holds a significant position, benefiting from strong government support for healthcare innovation and increasing demand for efficient healthcare solutions. The Asia Pacific region is witnessing rapid growth, driven by a rising middle class, increased smartphone penetration, and a growing awareness of digital health applications. Meanwhile, the Middle East and Africa are gradually emerging as potential markets, influenced by improving healthcare infrastructure and rising investments in technology. Overall, the geographical landscape reflects varied dynamics, with North America at the forefront, followed by Europe and promising growth in Asia Pacific, the Middle East, and Africa.

Drug Reference Apps Market- Country Insights

The Drug Reference Apps market is spearheaded by the United States, which dominates due to its advanced healthcare system, high adoption of technology, and significant investment in digital health innovations. The demand for reliable drug information and clinical decision support drives the growth of these applications. Following the U.S., Germany stands out in Europe, where strong healthcare regulations and a focus on patient safety foster a robust market for drug reference tools. The United Kingdom also contributes significantly, with an increasing emphasis on digital health solutions within its National Health Service. In Asia, China and India are rapidly gaining traction, driven by burgeoning smartphone usage, rising healthcare awareness, and a growing population eager for accessible health information. The evolving healthcare landscapes in these countries highlight their potential, making them critical markets in the Drug Reference Apps sector.

Drug Reference Apps Market- Competitive Landscape:

The competitive landscape of the Drug Reference Apps market is characterized by a mix of established players and emerging innovators. Leading companies such as Wolters Kluwer, Elsevier, and IBM Corporation have a significant foothold, offering comprehensive solutions that integrate data analytics and clinical insights. Epocrates and Medscape are popular among healthcare professionals for their user-friendly interfaces and extensive drug databases. Lexicomp and Clinical Pharmacology provide reliable drug information and interaction checking tools, enhancing patient safety. Cerner Corporation and UpToDate are also notable for their integration in electronic health records and clinical decision support systems. DrugBank stands out for its comprehensive drug data, while other companies continue to emerge, focusing on niche markets or specialized functionalities. This diverse competitive environment underscores the ongoing innovation and adaptability required to meet the evolving needs of healthcare providers and patients alike in the digital age. As competition intensifies, companies are focusing on expanding their product lines and entering new markets to capture a larger share, for instance, in December 2024 Bayer announced the acquisition of HiDoc Technologies, a digital health company specializing in gastrointestinal disorders, to strengthen its digital health capabilities and expand technology-enabled healthcare solutions.

Recent Developments:

On September 2024 ACTO, an AI-powered Intelligent Field Excellence platform, announced a USD 10 million investment in generative AI to enhance healthcare provider engagement across the life sciences industry. The initiative focuses on strengthening the "human touch" in omnichannel engagement strategies by enabling more personalized, data-driven interactions.

On October 2024 Suki, a healthcare startup specializing in AI assistants, secured USD 70 million in a Series D funding round led by Hedosophia, with participation from Venrock and March Capital. The funding supports the expansion of its AI-powered tools designed to reduce administrative burdens for healthcare providers, with potential integration of drug reference functionalities to further streamline clinical workflows.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DRUG REFERENCE APPS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • PillPack
  • Medisafe
  • Pill Identifier & Med Scanner
  • Mango Health
  • Drugs.com
  • MDCalc
  • Epocrates
  • Medscape
  • UpToDate Lexidrug (formerly Lexicomp)
  • Micromedex (Merative US L.P.)
  • MyTherapy

GLOBAL DRUG REFERENCE APPS MARKET, BY PRICING MODEL - MARKET ANALYSIS, 2019 - 2032

  • Free
  • Subscription-Based
  • Freemium

GLOBAL DRUG REFERENCE APPS MARKET, BY DEVICE- MARKET ANALYSIS, 2019 - 2032

  • Smartphones
  • Tablets
  • Desktops
  • Others

GLOBAL DRUG REFERENCE APPS MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

  • Drug Information & Interaction Checking
  • Clinical Decision Support
  • Patient Education
  • Others

GLOBAL DRUG REFERENCE APPS MARKET, BY END USE - MARKET ANALYSIS, 2019 - 2032

  • Healthcare Professionals
  • Hospitals & Clinics
  • Pharmacies
  • Patients
  • Others

GLOBAL DRUG REFERENCE APPS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Drug Reference Apps Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market
    • 2.1.1. Drug Reference Apps Market by Pricing Model
    • 2.1.2. Drug Reference Apps Market by Device
    • 2.1.3. Drug Reference Apps Market by Application
    • 2.1.4. Drug Reference Apps Market by End Use
    • 2.1.5. Drug Reference Apps Market by Country
    • 2.1.6. Drug Reference Apps Market by Region
  • 2.2. Competitive Insights

3. Drug Reference Apps Key Market Trends

  • 3.1. Drug Reference Apps Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Drug Reference Apps Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Drug Reference Apps Market Opportunities
  • 3.4. Drug Reference Apps Market Future Trends

4. Drug Reference Apps Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Drug Reference Apps Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Drug Reference Apps Market Landscape

  • 6.1. Drug Reference Apps Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Drug Reference Apps Market - By Pricing Model

  • 7.1. Overview
    • 7.1.1. Free
    • 7.1.2. Subscription-Based
    • 7.1.3. Freemium

8. Drug Reference Apps Market - By Device

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Device, 2024&2032 (%)
    • 8.1.2. Smartphones
    • 8.1.3. Tablets
    • 8.1.4. Desktops
    • 8.1.5. Others

9. Drug Reference Apps Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024&2032 (%)
    • 9.1.2. Drug Information & Interaction Checking
    • 9.1.3. Clinical Decision Support
    • 9.1.4. Patient Education
    • 9.1.5. Others

10. Drug Reference Apps Market - By End Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2024&2032 (%)
    • 10.1.2. Healthcare Professionals
    • 10.1.3. Hospitals & Clinics
    • 10.1.4. Pharmacies
    • 10.1.5. Patients
    • 10.1.6. Others

11. Drug Reference Apps Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Drug Reference Apps Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.2.4. North America Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
    • 11.2.5. North America Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 11.2.7. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.2.8.3. U.S. Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.2.8.4. U.S. Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.2.9.3. Canada Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.2.9.4. Canada Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.2.9.6. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Drug Reference Apps Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.3.4. Europe Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
    • 11.3.5. Europe Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 11.3.7. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.8.3. Germany Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.3.8.4. Germany Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.8.6. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.9.3. UK Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.3.9.4. UK Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.9.6. UK Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.10.3. France Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.3.10.4. France Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.10.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.11.3. Italy Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.3.11.4. Italy Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.11.6. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.12.3. Spain Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.3.12.4. Spain Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.12.6. Spain Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.13.6. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.14.3. Sweden Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.3.14.4. Sweden Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.14.6. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.15.3. Russia Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.3.15.4. Russia Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.15.6. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.16.3. Poland Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.3.16.4. Poland Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.16.6. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Drug Reference Apps Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.4.4. APAC Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
    • 11.4.5. APAC Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 11.4.7. APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.8.3. China Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.4.8.4. China Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.8.6. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.9.3. India Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.4.9.4. India Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.9.6. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.10.3. Japan Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.4.10.4. Japan Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.10.6. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.11.3. South Korea Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.4.11.4. South Korea Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.12.3. Australia Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.4.12.4. Australia Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.12.6. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.14.3. Thailand Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.4.14.4. Thailand Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.14.6. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.15.3. PhilippinesMarket Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.4.15.4. Philippines Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Drug Reference Apps Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.5.4. LATAM Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
    • 11.5.5. LATAM Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 11.5.7. LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.8.3. Brazil Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.5.8.4. Brazil Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.9.3. Mexico Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.5.9.4. Mexico Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.10.3. Argentina Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.5.10.4. Argentina Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.11.3. Colombia Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.5.11.4. Colombia Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Drug Reference Apps Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.6.4. MEA Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
    • 11.6.5. MEA Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 11.6.7. MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.6.9. UAE
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.9.3. UAE Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.6.9.4. UAE Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.6.9.5. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.6.9.6. UAE Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.10.3. Israel Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.6.10.4. Israel Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.6.10.6. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.11.3. Turkey Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.6.11.4. Turkey Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.12.3. Algeria Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.6.12.4. Algeria Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.13.3. Egypt Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.6.13.4. Egypt Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Pricing Model, 2019 - 2032 (US$ Billion)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Device, 2019 - 2032 (US$ Billion)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)

12. Key Vendor Analysis- Drug Reference Apps Market Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. PillPack
    • 12.2.2. Medisafe
    • 12.2.3. Pill Identifier & Med Scanner
    • 12.2.4. Mango Health
    • 12.2.5. Drugs.com
    • 12.2.6. MDCalc
    • 12.2.7. Epocrates
    • 12.2.8. Medscape
    • 12.2.9. UpToDate Lexidrug (formerly Lexicomp)
    • 12.2.10. Micromedex (Merative US L.P.)
    • 12.2.11. MyTherapy

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제